Pradeep Velumula

Dr. Pradeep Velumula

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2022 in Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
PVPradeep Velumula
Pradeep Velumula
FEFaesal Elbakoush
Faesal Elbakoush
CTCarl Tabb
Carl Tabb
AFAhmad Farooqi
Ahmad Farooqi
MLMirjana Lulic-Botica
Mirjana Lulic-Botica
MBMonika Bajaj
Monika Bajaj

18 February 2022 in Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
HEHiba El-Fadeel
Hiba El-Fadeel
PVPradeep Velumula
Pradeep Velumula
MLMirjana Lulic-Botica
Mirjana Lulic-Botica
GNGirija Natarajan
Girija Natarajan
RTRonald Thomas
Ronald Thomas
MBMonika Bajaj
Monika Bajaj

23 September 2022 in Cureus
Verified
Journal Article
Open access
PBPraveen kumar Boddu
Praveen kumar Boddu
PVPradeep Velumula
Pradeep Velumula
SSSaima Sharif
Saima Sharif
BMBajaj Monika
Bajaj Monika
Neonatal diabetes mellitus (NDM) is a rare condition with more than 20 monogenic genes associated with it. GLIS3 gene-encoded GLI similar protein 3, as a transcription factor, is involved in the development of the pancreas, liver, kidneys, eye, and thyroid. We report a preterm female neonate with coarse facial features and hyperglycemia, later diagnosed with neonatal diabetes mellitus, congenital hypothyroidism (CH), congenital glaucoma (CG), and renal cysts, secondary to GLIS3 gene mutation. It is a rare genetic disorder involving multiple organ systems with progressive development of symptoms requiring long-term surveillance and management.

1 April 2023 in Breastfeeding Medicine
Verified
Journal Article
Closed access
PVPradeep Velumula
Pradeep Velumula
FEFaesal Elbakoush
Faesal Elbakoush
HEHiba Elfadeel
Hiba Elfadeel
MLMirjana Lulic-Botica
Mirjana Lulic-Botica
GNGirija Natarajan
Girija Natarajan
MBMonika Bajaj
Monika Bajaj
Objective: To compare growth velocity (GV) in preterm infants fed mother's own milk (MOM) fortified with human milk-based fortifier (HMBF) to those who received donor human milk (DHM) fortified with HMBF. Study Design: A retrospective study of preterm infants with birth weight <1,250 g receiving an exclusive human milk diet. Maternal and infant charts were reviewed for feeding, growth, and short-term neonatal morbidities. Results: On regression analysis, after adjusting (gestational age, multiple births, antenatal steroids, and small for gestational age), no significant difference was observed between the two groups in GV from birth to 32 weeks postmenstrual age ( β -coefficient 0.83, 95% confidence interval [CI]: −0.47 to 2.14, p = 0.21), GV from the day of regaining of birth weight to discharge ( β -coefficient −0.015, 95% CI: −1.08 to 1.05, p = 0.98). The rate of Grade 3 and 4 intraventricular hemorrhage was significantly higher in the DHM group (19.6% compared to 5.5% in MOM, p = 0.03). Conclusion: At our institution, there was no difference in GV of preterm infants fed HMBF-fortified MOM versus HMBF-fortified DBM.

1 February 2020 in Pediatric Annals
Verified
Journal Article
Closed access
PDF file
PVPradeep Velumula
Pradeep Velumula
SJSanket Jani
Sanket Jani
NKNeelakanta Kanike
Neelakanta Kanike
SCSanjay Chawla
Sanjay Chawla
Preterm infants and term infants with complex medical conditions are often discharged home with technological support. There is a scarcity of evidence-based guidelines for post-discharge management of these infants at high risk. Common diagnoses necessitating the need for respiratory support and/or monitoring devices include apnea of prematurity and bronchopulmonary dysplasia for preterm infants, and upper airway anomalies, central nervous system disorders, and neuromuscular disorders for term infants. Some infants who are unable to receive complete oral feeds for various reasons are sometimes discharged home with nasogastric or gastrostomy tube feeds. For safe patient care at home and reduction of emergency department visits, there should be proper transition of care from hospital to primary care provider, and appropriate instruction of caregivers for care of the infant including teaching about medications, feeding, and management of medical devices. Primary care providers should be aware of these common supportive devices and their complications to provide timely intervention if needed. [ Pediatr Ann . 2020;49(2):e88–e92. ]

12 December 2022 in Perfusion
Verified
Journal Article
Closed access
OSObeid Shafi
Obeid Shafi
TMTanveer Mir
Tanveer Mir
DLDaniel Liu
Daniel Liu
PVPradeep Velumula
Pradeep Velumula
SLSibghat Tul Llah
Sibghat Tul Llah
RKRitesh Korumilli
Ritesh Korumilli
Objectives: Extracorporeal membrane oxygenation (ECMO) is an increasingly used mode of critical care support for pediatric patients refractory to conventional therapy. We evaluated the characteristics, outcomes, and readmissions rates for pediatric ECMO in the United States. Methods: Data was extracted from the Nationwide Readmissions Database, a database designed to support national readmissions analyses, for patients aged 1–18 years undergoing ECMO between 2012–2018. Baseline demographics, comorbidities, and characteristics were identified using International Classification of Diseases codes. Results: Out of 897,117 index pediatric hospitalizations, 3706 patients underwent ECMO [median age 9 years (IQR 2,15); 51.6% males]. 2246 (60.6%) patients survived to hospital discharge, with a 30-day readmissions rate of 17% among survivors. Cardiac conditions associated with ECMO were congenital heart disease (25.3%), cardiogenic shock (23.6%), and congestive heart failure (16.2%). The common respiratory associations were sepsis (36.2%), pneumonia (35.6%), and asthma (15.4%). Patients who survived were more likely to have diagnoses of asthma, bronchiolitis, myocarditis, pneumonia, and sepsis. Acute kidney injury (51.5%), disseminated intravascular coagulation (22.5%), and surgical site bleeding (12.7%) were the commonly associated complications. The trend for yearly survival rates was not statistically significant (linear p-trend = 0.38). Conclusions: Pediatric ECMO continues to be associated with notable mortality and complication rates. We did not observe a meaningful trend for the yearly survival rates over the study period, and over one-sixth of survivors were readmitted within 30-days. More research is needed to identify patients at high risk of mortality and readmissions, to help target resources more efficiently and improve survival.